Suppr超能文献

CGX,一种传统草药配方,在大鼠中的抗纤维化作用及其机制。

Antifibrotic effects of CGX, a traditional herbal formula, and its mechanisms in rats.

机构信息

Liver-Immune Research Center, Daejeon Oriental Hospital of Daejeon University, 22-5 Daeheung-dong, Jung-gu, Daejeon 301-704, Republic of Korea.

出版信息

J Ethnopharmacol. 2010 Feb 3;127(2):534-42. doi: 10.1016/j.jep.2009.10.001. Epub 2009 Oct 13.

Abstract

AIM

CGX is a modification of a traditional herbal medicine for "liver cleaning," which is used to treat various chronic liver disorders in oriental clinics. This study investigated the antifibrotic effects and associated mechanisms of CGX.

MATERIALS AND METHODS

Liver fibrosis was induced in rats by dimethylnitrosamine (DMN; 10 mg kg(-1), ip) injection on 3 consecutive days per week for 4 weeks. CGX (100 or 200 mg kg(-1), po) was administrated once a day for 4 weeks. Three cell lines (HepG2, RAW 264.7, and HSC-T6) were used to examine its mechanisms.

RESULTS

CGX treatment dramatically ameliorated the change in liver and spleen weight and serum albumin (p<0.01), aspartate transaminase (p<0.01), alanine transaminase (p<0.01), alkaline phosphatase (p<0.01), and total bilirubin (p<0.01) levels. Histopathologically, CGX administration decreased necrosis, inflammatory cell infiltration, and collagen accumulation. The antifibrotic effects of CGX were confirmed from hydroxyproline determination and the reduction in the numbers of activated hepatic stellate cells. In addition, antioxidant proteins, glutathione content, and glutathione peroxidase, catalase, and superoxide dismutase activities were maintained in the CGX-treated groups compared with the DMN group. CGX downregulated fibrosis-related genes (inducible nitric oxide synthase, tumor necrosis factor-alpha, transforming growth factor-beta, connective tissue growth factor, and platelet-derived growth factor-beta) and decreased the protein levels of profibrotic cytokines (transforming growth factor-beta and platelet-derived growth factor-beta) in liver tissues. In the cell line-based studies, CGX showed supportive effects, such as the protection of hepatocytes from CCl(4)-toxicity, inhibition of NO production in RAW 264.7 cells, and inactivation of hepatic stellate cells.

CONCLUSION

These results demonstrated the antifibrotic effects of CGX and the corresponding mechanisms associated with sustaining the antioxidative system and inhibiting hepatic stellate cell activation via the downregulation of fibrogenic cytokines.

摘要

目的

CGX 是一种传统的“清肝”草药的改良品,用于治疗东方诊所的各种慢性肝脏疾病。本研究调查了 CGX 的抗纤维化作用及其相关机制。

材料和方法

用二甲基亚硝胺(DMN;10mgkg(-1),腹腔注射)每周连续 3 天注射诱导大鼠肝纤维化,共 4 周。CGX(100 或 200mgkg(-1),口服)每天给药 1 次,共 4 周。使用三种细胞系(HepG2、RAW 264.7 和 HSC-T6)来研究其机制。

结果

CGX 治疗显著改善了肝脾重量和血清白蛋白(p<0.01)、天冬氨酸转氨酶(p<0.01)、丙氨酸转氨酶(p<0.01)、碱性磷酸酶(p<0.01)和总胆红素(p<0.01)水平的变化。组织病理学检查显示,CGX 给药减少了坏死、炎症细胞浸润和胶原堆积。CGX 对羟脯氨酸测定和活化肝星状细胞数量减少的确认显示出抗纤维化作用。此外,与 DMN 组相比,CGX 处理组的抗氧化蛋白、谷胱甘肽含量以及谷胱甘肽过氧化物酶、过氧化氢酶和超氧化物歧化酶的活性得到维持。CGX 下调纤维化相关基因(诱导型一氧化氮合酶、肿瘤坏死因子-α、转化生长因子-β、结缔组织生长因子和血小板衍生生长因子-β),并降低肝组织中促纤维化细胞因子(转化生长因子-β和血小板衍生生长因子-β)的蛋白水平。在基于细胞系的研究中,CGX 显示出支持作用,例如保护肝细胞免受 CCl(4)毒性、抑制 RAW 264.7 细胞中 NO 的产生以及使肝星状细胞失活。

结论

这些结果表明 CGX 具有抗纤维化作用,以及通过下调纤维生成细胞因子维持抗氧化系统和抑制肝星状细胞活化的相应机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验